|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012.
|
|
2
|
Jenkinson F and Steele RJ: Colorectal
cancer screening-methodology. Surgeon. 8:164–171. 2010.
|
|
3
|
Kim MS, Lee J and Sidransky D: DNA
methylation markers in colorectal cancer. Cancer Metastasis Rev.
29:181–206. 2010.
|
|
4
|
Kondo Y and Issa JP: Epigenetic changes in
colorectal cancer. Cancer Metastasis Rev. 23:29–39. 2004.
|
|
5
|
Baek YH, Chang E, Kim YJ, et al: Stool
methylation-specific polymerase chain reaction assay for the
detection of colorectal neoplasia in Korean patients. Dis Colon
Rectum. 52:1452–1459; discussion 1459–1463. 2009.
|
|
6
|
Leung WK, To KF, Man EP, et al: Detection
of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal
samples of patients with colorectal cancer or polyps. Am J
Gastroenterol. 102:1070–1076. 2007.
|
|
7
|
Petko Z, Ghiassi M, Shuber A, et al:
Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in
fecal DNA from patients with colorectal polyps. Clin Cancer Res.
11:1203–1209. 2005.
|
|
8
|
Ausch C, Kim YH, Tsuchiya KD, et al:
Comparative analysis of PCR-based biomarker assay methods for
colorectal polyp detection from fecal DNA. Clin Chem. 55:1559–1563.
2009.
|
|
9
|
Abbaszadegan MR, Tavasoli A, Velayati A,
et al: Stool-based DNA testing, a new noninvasive method for
colorectal cancer screening, the first report from Iran. World J
Gastroenterol. 13:1528–1533. 2007.
|
|
10
|
Frommer M, McDonald LE, Millar DS, et al:
A genomic sequencing protocol that yields a positive display of
5-methylcytosine residues in individual DNA strands. Proc Natl Acad
Sci USA. 89:1827–1831. 1992.
|
|
11
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2009. CA Cancer J Clin. 59:225–249. 2009.
|
|
12
|
Vernon SW: Participation in colorectal
cancer screening: a review. J Natl Cancer Inst. 89:1406–1422.
1997.
|
|
13
|
Winawer S, Fletcher R, Rex D, et al;
Gastrointestinal Consortium Panel. Colorectal cancer screening and
surveillance: clinical guidelines and rationale-update based on new
evidence. Gastroenterology. 124:544–560. 2003.
|
|
14
|
Ahlquist DA and Shuber AP: Stool screening
for colorectal cancer: evolution from occult blood to molecular
markers. Clin Chim Acta. 315:157–168. 2002.
|
|
15
|
Ahlquist DA, Skoletsky JE, Boynton KA, et
al: Colorectal cancer screening by detection of altered human DNA
in stool: feasibility of a multitarget assay panel.
Gastroenterology. 119:1219–1227. 2000.
|
|
16
|
Wu GH, Wang YM, Yen AM, et al:
Cost-effectiveness analysis of colorectal cancer screening with
stool DNA testing in intermediate-incidence countries. BMC Cancer.
6:1362006.
|
|
17
|
Luo YX, Chen DK, Song SX, et al: Aberrant
methylation of genes in stool samples as diagnostic biomarkers for
colorectal cancer or adenomas: a meta-analysis. Int J Clin Pract.
65:1313–1320. 2011.
|
|
18
|
Suzuki H, Gabrielson E, Chen W, et al: A
genomic screen for genes upregulated by demethylation and histone
deacetylase inhibition in human colorectal cancer. Nat Genet.
31:141–149. 2002.
|
|
19
|
Müller HM, Oberwalder M, Fiegl H, et al:
Methylation changes in faecal DNA: a marker for colorectal cancer
screening? Lancet. 363:1283–1285. 2004.
|
|
20
|
Huang Z, Li L and Wang J: Hypermethylation
of SFRP2 as a potential marker for stool-based detection of
colorectal cancer and precancerous lesions. Dig Dis Sci.
52:2287–2291. 2007.
|
|
21
|
Hellebrekers DM, Lentjes MH, van den Bosch
SM, et al: GATA4 and GATA5 are potential tumor suppressors and
biomarkers in colorectal cancer. Clin Cancer Res. 15:3990–3997.
2009.
|
|
22
|
Melotte V, Lentjes MH, van den Bosch SM,
et al: N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor
suppressor gene and potential biomarker for colorectal cancer. J
Natl Cancer Inst. 101:916–927. 2009.
|
|
23
|
Lodish H, Baltimore D, Berk A, Zipursky
SL, Mastudaira P and Darnell J: Molecular cell biology. 3rd
Edition. Scientific American Books; New York, NY: 1995
|
|
24
|
Chen WD, Han ZJ, Skoletsky J, et al:
Detection in fecal DNA of colon cancer-speciic methylation of the
nonexpressed vimentin gene. J Natl Cancer Inst. 97:1124–1132.
2005.
|
